Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine
Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...
Download Unicorn Signals App
By EquityPandit
